Stool Softener Laxative Tablet
NDC Package 0363-8780-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Stool Softener Laxative (docusate sodium and sennosides) tablets is take only by mouth. This formulation utilizes a tablet delivery system. Marketed by Walgreens, this product is identified by NDC 0363-8780 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
0363-8780-60
Package Description
1 BOTTLE in 1 BOX / 60 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
00363878060
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Stool Softener Laxative
Non-Proprietary Name
Docusate Sodium And Sennosides
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided doses.adults and children 12 years and oldertake 2-4 tablets daily children 6 to under 12 years of agetake 1-2 tablets daily children 2 to under 6 years of age take up to 1 tablet daily children under 2 ask a doctor 

Regulatory & Marketing

Labeler Name
Walgreens
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-30-2020
End Marketing Date
07-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0363-8780). Click a package code to view its specific billing and regulatory data.

200 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0363-8780-60 identifies a specific commercial package of 1 bottle in 1 box / 60 tablet in 1 bottle of Stool Softener Laxative, a human over the counter drug labeled by Walgreens. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens on July 30, 2020.

How is this Walgreens product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363878060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0363-8780-60
11-Digit CMS (5-4-2)
00363-8780-60

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.